Literature DB >> 21781251

Nanoscale studies of protein-membrane interactions in blood clotting.

J H Morrissey1, E Tajkhorshid, C M Rienstra.   

Abstract

Most of the steps in the blood clotting cascade require clotting proteins to bind to membrane surfaces with exposed phosphatidylserine. In spite of the importance of these protein-membrane interactions, we still lack a detailed understanding of how clotting proteins interact with membranes and how membranes contribute so profoundly to catalysis. Our laboratories are using multidisciplinary approaches to explore, at atomic-resolution, how blood clotting protein complexes assemble and function on membrane surfaces.
© 2011 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21781251      PMCID: PMC3151027          DOI: 10.1111/j.1538-7836.2011.04300.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  39 in total

1.  The omega-loop region of the human prothrombin gamma-carboxyglutamic acid domain penetrates anionic phospholipid membranes.

Authors:  L A Falls; B C Furie; M Jacobs; B Furie; A C Rigby
Journal:  J Biol Chem       Date:  2001-04-18       Impact factor: 5.157

2.  Single-molecule height measurements on microsomal cytochrome P450 in nanometer-scale phospholipid bilayer disks.

Authors:  Timothy H Bayburt; Stephen G Sligar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

3.  Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins.

Authors:  Mingdong Huang; Alan C Rigby; Xavier Morelli; Marianne A Grant; Guiqing Huang; Bruce Furie; Barbara Seaton; Barbara C Furie
Journal:  Nat Struct Biol       Date:  2003-08-17

Review 4.  Enhancement of vitamin-K-dependent protein function by modification of the gamma-carboxyglutamic acid domain: studies of protein C and factor VII.

Authors:  G L Nelsestuen
Journal:  Trends Cardiovasc Med       Date:  1999-08       Impact factor: 6.677

5.  Interaction of an amphitropic protein (factor Xa) with membrane models in a complex system.

Authors:  M F Lecompte
Journal:  Biochim Biophys Acta       Date:  2005-08-05

6.  Proposed structural models of the prothrombinase (FXa-FVa) complex.

Authors:  Ludovic Autin; Mårten Steen; Björn Dahlbäck; Bruno O Villoutreix
Journal:  Proteins       Date:  2006-05-15

7.  Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor.

Authors:  Y Z Ohkubo; J H Morrissey; E Tajkhorshid
Journal:  J Thromb Haemost       Date:  2010-02-24       Impact factor: 5.824

8.  Functional reconstitution of Beta2-adrenergic receptors utilizing self-assembling Nanodisc technology.

Authors:  Andrew J Leitz; Timothy H Bayburt; Alexander N Barnakov; Barry A Springer; Stephen G Sligar
Journal:  Biotechniques       Date:  2006-05       Impact factor: 1.993

9.  Molecular dynamics simulations of discoidal bilayers assembled from truncated human lipoproteins.

Authors:  Amy Y Shih; Ilia G Denisov; James C Phillips; Stephen G Sligar; Klaus Schulten
Journal:  Biophys J       Date:  2004-11-08       Impact factor: 4.033

10.  Localization of phosphatidylserine binding sites to structural domains of factor Xa.

Authors:  Arvind Srivastava; Jianfang Wang; Rinku Majumder; Alireza R Rezaie; Johan Stenflo; Charles T Esmon; Barry R Lentz
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

View more
  15 in total

1.  Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data.

Authors:  Hiroshi Deguchi; Yajnavalka Banerjee; Sunia Trauger; Gary Siuzdak; Ewa Kalisiak; José A Fernández; Linh Hoang; Minerva Tran; Subramanian Yegneswaran; Darlene J Elias; John H Griffin
Journal:  Blood       Date:  2015-07-14       Impact factor: 22.113

2.  Nanodiscs: A Controlled Bilayer Surface for the Study of Membrane Proteins.

Authors:  Mark A McLean; Michael C Gregory; Stephen G Sligar
Journal:  Annu Rev Biophys       Date:  2018-03-01       Impact factor: 12.981

3.  Lipid specificity of the membrane binding domain of coagulation factor X.

Authors:  M P Muller; Y Wang; J H Morrissey; E Tajkhorshid
Journal:  J Thromb Haemost       Date:  2017-09-01       Impact factor: 5.824

Review 4.  Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.

Authors:  Julia E Geddings; Nigel Mackman
Journal:  Blood       Date:  2013-06-24       Impact factor: 22.113

5.  A microscopic view of phospholipid insertion into biological membranes.

Authors:  Josh V Vermaas; Emad Tajkhorshid
Journal:  J Phys Chem B       Date:  2013-12-16       Impact factor: 2.991

6.  Structural and functional studies of γ-carboxyglutamic acid domains of factor VIIa and activated Protein C: role of magnesium at physiological calcium.

Authors:  Kanagasabai Vadivel; Sayeh Agah; Amanda S Messer; Duilio Cascio; Madhu S Bajaj; Sriram Krishnaswamy; Charles T Esmon; Kaillathe Padmanabhan; S Paul Bajaj
Journal:  J Mol Biol       Date:  2013-02-20       Impact factor: 5.469

7.  Characterization of platelet aminophospholipid externalization reveals fatty acids as molecular determinants that regulate coagulation.

Authors:  Stephen R Clark; Christopher P Thomas; Victoria J Hammond; Maceler Aldrovandi; Gavin W Wilkinson; Keith W Hart; Robert C Murphy; Peter W Collins; Valerie B O'Donnell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

Review 8.  New players in haemostasis and thrombosis.

Authors:  Julia E Geddings; Nigel Mackman
Journal:  Thromb Haemost       Date:  2014-02-27       Impact factor: 5.249

Review 9.  Regulation of tissue factor coagulant activity on cell surfaces.

Authors:  L V M Rao; U R Pendurthi
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

10.  Cardiolipin interaction with subunit c of ATP synthase: solid-state NMR characterization.

Authors:  Ségolène Laage; Yisong Tao; Ann E McDermott
Journal:  Biochim Biophys Acta       Date:  2014-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.